Preclinical Evaluation of Anticancer Efficacy and Pharmacological Properties of FBA-TPQ, a Novel Synthetic Makaluvamine Analog

We have recently designed and synthesized a novel iminoquinone anticancer agent, 7-(4-fluorobenzylamino)-1,3,4,8-tetrahydropyrrolo[4,3,2-de]quinolin-8(1H)-one (FBA-TPQ) and initiated its preclinical development. Herein we investigated its efficacy, safety, and pharmacokinetics in in vitro and in viv...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhang, Xiangrong, Xu, Hongxia, Zhang, Xu, Voruganti, Sukesh, Murugesan, Srinivasan, Nadkarni, Dwayaja H., Velu, Sadanandan E., Wang, Ming-Hai, Wang, Wei, Zhang, Ruiwen
Format: Artigo
Langue:Inglês
Publié: MDPI 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3397457/
https://ncbi.nlm.nih.gov/pubmed/22822362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md10051138
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires